News Briefs: Draft NBPP Did Not Address Accumulators

  • Oct 10, 2024

    HHS did not address copay accumulators in the 2026 proposed Notice of Benefit and Payment Parameters (NBPP), as patient advocacy groups had hoped it would. Rather, the agency said that it and the Departments of Labor and Treasury plan to issue a future notice of proposed rulemaking that addresses “the applicability of drug manufacturer support to the annual limitation on cost sharing.” Posted online on Oct. 4 and published in the Federal Register on Oct. 10, the proposed NBPP also did not align the use of copay maximizers, which declare certain drugs non-essential health benefits, in large group market plans and self-funded group plans with HHS’s stance barring the use of maximizers in nongrandfathered individual and small group market plans, as stated in the final 2025 NBPP. Read more
    © 2024 MMIT
  • Angela Maas

    Angela has an extensive background of editing, reporting and writing for trade and consumer publications. She has written Radar on Specialty Pharmacy since she joined AIS Health in 2005 and has broad knowledge of the various issues at play within the space. She also has written for Spotlight on Market Access since its 2017 launch. Before joining AIS Health, she was managing editor at Employee Benefit News and Employee Benefit News Canada and managing editor at Hem Aware (a hemophilia publication), Lupus Living and Momentum (a multiple sclerosis publication). She has a B.A. in English and an M.A. in British literature from Arizona State University.

The Latest
Meet Our Reporters

Meet Our Reporters

×